178 related articles for article (PubMed ID: 21724534)
41. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
[TBL] [Abstract][Full Text] [Related]
42. Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
[TBL] [Abstract][Full Text] [Related]
43. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
[TBL] [Abstract][Full Text] [Related]
44. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
45. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
[TBL] [Abstract][Full Text] [Related]
46. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
47. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
[TBL] [Abstract][Full Text] [Related]
48. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.
Kushnir VA; Seifer DB; Barad DH; Sen A; Gleicher N
J Assist Reprod Genet; 2017 Sep; 34(9):1105-1113. PubMed ID: 28643088
[TBL] [Abstract][Full Text] [Related]
49. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
[TBL] [Abstract][Full Text] [Related]
50. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens.
Gleicher N; Kushnir VA; Darmon SK; Wang Q; Zhang L; Albertini DF; Barad DH
J Steroid Biochem Mol Biol; 2017 Mar; 167():144-152. PubMed ID: 27993552
[TBL] [Abstract][Full Text] [Related]
51. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
Das M; Gillott DJ; Saridogan E; Djahanbakhch O
Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
[TBL] [Abstract][Full Text] [Related]
52. [Effect of follicle stimulating hormone on the secretion of anti-mullerian hormone in the granulosa cells in patients with polycystic ovarian syndrome].
Li Y; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):5-8. PubMed ID: 22455685
[TBL] [Abstract][Full Text] [Related]
53. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
54. The role of anti-Müllerian hormone in female fertility and infertility - an overview.
Grynnerup AG; Lindhard A; Sørensen S
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322
[TBL] [Abstract][Full Text] [Related]
55. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
[TBL] [Abstract][Full Text] [Related]
56. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
Qi X; Pang Y; Qiao J
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
[TBL] [Abstract][Full Text] [Related]
57. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
[TBL] [Abstract][Full Text] [Related]
58. Anti-Mullerian hormone--is it a crystal ball for predicting ovarian ageing?
Loh JS; Maheshwari A
Hum Reprod; 2011 Nov; 26(11):2925-32. PubMed ID: 21849297
[TBL] [Abstract][Full Text] [Related]
59. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
[TBL] [Abstract][Full Text] [Related]
60. Is there a place for AMH testing in Canada?
Green JA; Graves G
J Obstet Gynaecol Can; 2011 Jun; 33(6):628-632. PubMed ID: 21846454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]